Beta Bionics, Inc. (BBNX) income statement
BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 11/3010% below fair value
$13.36+0.04 (+0.30%)
Close on Nov 20, 2026Market cap $726.34MP/E –Yield –
Beta Bionics, Inc. financial ratios
See a number that looks wrong?